Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Omowunmi Sonubi
“Maximum Tolerated Dose” Versus “Fixed Low-Dose” Hydroxyurea for Treatment of Adults With Sickle Cell Anemia
American Journal of Hematology
Hematology
Related publications
Hydroxyurea Treatment Decreases Glomerular Hyperfiltration in Children With Sickle Cell Anemia
American Journal of Hematology
Hematology
Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Hydroxyurea Enhances Fetal Hemoglobin Production in Sickle Cell Anemia.
Journal of Clinical Investigation
Medicine
Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
An Application of Reinforced Urn Processes to Determining Maximum Tolerated Dose
Statistics and Probability Letters
Uncertainty
Statistics
Probability
Assessment of Genotoxicity Associated With Hydroxyurea Therapy in Children With Sickle Cell Anemia.
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Hydroxyurea Prevents Onset and Progression of Albuminuria in Children With Sickle Cell Anemia
American Journal of Hematology
Hematology
The Influence of Hydroxyurea on Oxidative Stress in Sickle Cell Anemia
Revista Brasileira de Hematologia e Hemoterapia
P2.17-10 Daily Low–Dose Cisplatin and High Dose Radiotherapy for Elderly Patients With Stage III NSCLC Is Well Tolerated.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary